Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
5 "Ye-Young Rhee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Case Studies
Hyalinizing Trabecular Tumor of the Thyroid Gland, a Diagnostic Challenge in Fine-Needle Aspiration Cytology: Case Report
Ye-Young Rhee, Hong Kyu Jung, Se Hoon Kim, Soo Hee Kim
J Pathol Transl Med. 2018;52(4):252-256.   Published online June 11, 2018
DOI: https://doi.org/10.4132/jptm.2018.04.28
  • 8,780 View
  • 176 Download
  • 6 Web of Science
  • 8 Crossref
AbstractAbstract PDF
Hyalinizing trabecular tumor (HTT) is a rare thyroid tumor with low to minimal malignant potential. HTT is often misinterpreted as other thyroid tumors, including papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC), on fine-needle aspiration (FNA) cytology, because of its overlapping cytologic features, such as nuclear grooves and intranulcear pseudoinclusions. Although cytopathologists cannot definitely conclude HTT by FNA cytology, suspicion of HTT is necessary to avoid misdiagnosing HTT as PTC or MTC and to avoid unnecessary aggressive treatment. Here, we report a case of HTT with novel cytologic features in CellPrep liquid based cytology that was diagnosed as suspicious for papillary carcinoma by FNA and finally diagnosed as HTT in the surgical specimen.

Citations

Citations to this article as recorded by  
  • Cytomorphological traits of fine-needle aspirates of hyalinizing trabecular tumor of the thyroid gland: A brief report
    Fei Wang, Yufei Liu
    Indian Journal of Pathology and Microbiology.2024; 67(1): 128.     CrossRef
  • Total thyroidectomy can still remain the method of choice in some Bethesda III cases
    Jindrich Lukas, Barbora Hintnausova, Vlasta Sykorova, Martin Syrucek, Marek Maly, Jaroslava Duskova
    Biomedical Papers.2023; 167(1): 61.     CrossRef
  • Diagnostic clues for hyalinizing trabecular tumor on fine needle aspiration cytology
    Lone Nielsen, Ana María Colino Gallardo, Pablo Pérez Alonso, Luis Ortega Medina, Esthefanía Latorre García, Cristina Díaz del Arco, Reyes Bergillos Jiménez, Lorenzo Alarcón García, Marta Cruz Blanco, Jesús Vega González, Montserrat De la Torre Serrano, Ma
    Cytojournal.2023; 20: 19.     CrossRef
  • Clinical Characteristics of the Hyalinizing Trabecular Tumor
    Byung-Chang Kim, Shin Jeong Pak, Jae Won Cho, Won Woong Kim, Yu-mi Lee, Tae-Yon Sung, Jung Hwan Baek, Ki-Wook Chung
    Journal of Endocrine Surgery.2022; 22(4): 116.     CrossRef
  • A Case of Multifocal Hyalinizing Trabecular Tumors of the Thyroid Gland
    Suhwan Jeong, Hanaro Park
    Journal of Clinical Otolaryngology Head and Neck Surgery.2021; 32(3): 308.     CrossRef
  • The Diagnosis of Hyalinizing Trabecular Tumor: A Difficult and Controversial Thyroid Entity
    Esther Diana Rossi, Mauro Papotti, William Faquin, Luigi Maria Larocca, Liron Pantanowitz
    Head and Neck Pathology.2020; 14(3): 778.     CrossRef
  • A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration
    Marco Dell’Aquila, Carmen Gravina, Alessandra Cocomazzi, Sara Capodimonti, Teresa Musarra, Stefania Sfregola, Vincenzo Fiorentino, Luca Revelli, Maurizio Martini, Guido Fadda, Liron Pantanowitz, Luigi Maria Larocca, Esther Diana Rossi
    Cancer Cytopathology.2019; 127(6): 390.     CrossRef
  • GLIS rearrangements in thyroid nodules: A key to preoperative diagnosis of hyalinizing trabecular tumor
    Marina N. Nikiforova, Yuri E. Nikiforov, N. Paul Ohori
    Cancer Cytopathology.2019; 127(9): 560.     CrossRef
Merkel Cell Carcinoma Metastatic to Pleural Fluid: A Case Report
Ye-Young Rhee, Soo Hee Kim, Eun Kyung Kim, Se Hoon Kim
J Pathol Transl Med. 2018;52(3):206-209.   Published online November 23, 2017
DOI: https://doi.org/10.4132/jptm.2017.11.10
  • 6,347 View
  • 130 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Merkel cell carcinoma (MCC) is a rare aggressive neuroendocrine carcinoma of the skin that shows locoregional or distant metastasis. Metastasis of MCC to body cavity effusion is extremely rare; only three cases have been reported so far. Metastatic MCC in effusion cytology shows small blue round cells with fine stippled chromatin like other small blue round cell tumors such as small cell lung carcinoma or lymphoma. The diagnosis of metastatic MCC can grant patients good chances at recently advanced therapeutic options. Here, we present a case of metastatic MCC to pleural effusion with characteristic single file-like pattern.

Citations

Citations to this article as recorded by  
  • Merkel cell carcinoma presenting as a malignant pleural effusion post‐COVID‐19 hospitalization: A case report and literature review
    Joel Lanceta, Mesut Toprak, Oana C. Rosca
    Diagnostic Cytopathology.2022;[Epub]     CrossRef
  • Cytology coupled with immunocytochemistry identifies Merkel cell carcinoma: A rare intruder in the cerebrospinal fluid
    Reetu Kundu, Brijdeep Singh, Pranab Dey
    Cytopathology.2022; 33(4): 530.     CrossRef
  • Derrame pleural por carcinoma de células de Merkel
    María J. Soler-Sempere, María O. Alvárez-Fernández, Isabel Padilla-Navas, María Cabezas-Macián, Jose F. Sánchez-Hernández, Eduardo García-Pachón
    Archivos de Bronconeumología.2021; 57(11): 715.     CrossRef
  • A rare case of pleural localisation of both metastatic Merkel cell carcinoma and chronic lymphocytic leukaemia
    Elise Kaspi, Shirley Fritz, Julien Colle, Florent Amatore, Diane Frankel, Patrice Roll
    Cytopathology.2021; 32(3): 367.     CrossRef
  • Merkel cell carcinoma with pleural effusion
    María J. Soler-Sempere, María O. Alvárez-Fernández, Isabel Padilla-Navas, María Cabezas-Macián, Jose F. Sánchez-Hernández, Eduardo García-Pachón
    Archivos de Bronconeumología (English Edition).2021; 57(11): 715.     CrossRef
Original Articles
Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Lesions
Hae Woon Baek, Min Jee Park, Ye-Young Rhee, Kyoung Bun Lee, Min A Kim, In Ae Park
J Pathol Transl Med. 2015;49(1):52-60.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.26
  • 9,366 View
  • 84 Download
  • 31 Web of Science
  • 32 Crossref
AbstractAbstract PDF
Background
Endoscopic ultrasound–guided fine needle aspiration cytology (EUS-FNAC) is currently the most commonly used procedure for obtaining cytologic specimens of the pancreas. It is accurate, minimally invasive, safe and cost-effective. However, there is discrepancy between cytological and surgical diagnoses. This study was aimed at evaluating the diagnostic accuracy of EUS-FNAC of the pancreas. Methods: We performed a retrospective review of 191 cases of pancreatic lesions initially diagnosed by EUS-FNAC with subsequent histological diagnosis between 2010 and 2012 in the Department of Pathology, Seoul National University Hospital. Cytologic and surgical diagnoses were categorized into five groups: negative, benign, atypical, malignant, and insufficient for diagnosis. Subsequently, 167 cases with satisfactory yield in both surgical and cytology specimens were statistically analyzed to determine correlations with diagnosis. Results: In comparison to surgical diagnoses, cytologic diagnoses were true-positive in 103 cases (61.7%), true-negative in 28 cases (16.8%), false-positive in 9 cases (5.4%), and false-negative in 27 cases (16.1%). The diagnostic accuracy was 78.4%, sensitivity was 79.2%, and specificity was 75.7%. The positive predictive value was 92.0%, and negative predictive value was 50.9%. Conclusions: EUS-FNAC has high accuracy, sensitivity, specificity and positive predictive value. Overcoming the limitations of EUS-FNAC will make it a useful and reliable diagnostic tool for accurate evaluation of pancreatic lesions.

Citations

Citations to this article as recorded by  
  • Reporting Pancreatic FNAC using the Papanicolaou System: Still a Diagnostic Challenge
    Parul Verma, Saloni Goyal, Ruchita Tyagi, Mehar Ghuman, Ramit Mahajan, Arshneet Kaur Selhi, Harpreet Kaur, Pavneet Kaur Selhi
    Journal of Cytology.2024; 41(2): 123.     CrossRef
  • miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic
    Hiroki Ueda, Hidenori Takahashi, Shogo Kobayashi, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi
    Annals of Surgical Oncology.2024;[Epub]     CrossRef
  • Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis
    Hiroki Ueda, Hidenori Takahashi, Ryoto Sakaniwa, Tetsuhisa Kitamura, Shogo Kobayashi, Yoshito Tomimaru, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi
    Pancreatology.2024; 24(7): 1097.     CrossRef
  • Comparison of Endoscopic Ultrasound-Guided Fine-Needle Aspiration with Fine-Needle Biopsy for Solid Gastrointestinal Lesions: A Randomized Crossover Single-Center study
    Shivaraj Afzalpurkar, Vijay Kumar Rai, Nikhil Sonthalia, Gajanan Rodge, Awanesh Tewary, Mahesh Goenka
    Journal of Digestive Endoscopy.2023; 14(01): 014.     CrossRef
  • Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
    María Victoria García-Ortiz, Pablo Cano-Ramírez, Marta Toledano-Fonseca, Enrique Aranda, Antonio Rodríguez-Ariza
    Biomarker Research.2023;[Epub]     CrossRef
  • Grading pancreatic adenocarcinomas on fine needle aspiration cytology. The outstanding issues
    Mrinmay Kumar Mallik, Laila Rafiq Qadan, Asit Kumar Mohanty, Ali Alali, Kusum Kapila
    Cytopathology.2023;[Epub]     CrossRef
  • The impact of preoperative EUS-FNA for distal resectable pancreatic cancer: Is it really effective enough to take risks?
    Jin-Seok Park, Jae Hoon Lee, Tae Jun Song, Joune Seup Lee, Seok Jung Jo, Dong Wook Oh, Ki Byung Song, Dae Wook Hwang, Do Hyun Park, Sang Soo Lee, Song Cheol Kim, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim
    Surgical Endoscopy.2022; 36(5): 3192.     CrossRef
  • Magnetic Resonance Imaging Radiomics‐Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study
    Zhenshan Shi, Chengle Ma, Xinming Huang, Dairong Cao
    Journal of Magnetic Resonance Imaging.2022; 55(3): 823.     CrossRef
  • Role of Pathologist in the Era of Image-Guided and EUS-Guided Aspirations: A 10-Year Study at a Single Tertiary Care Oncology Institute in North India
    Gurudutt Gupta, Anila Sharma, Meenakshi Kamboj, Anurag Sharma, Sunil Pasricha, Garima Durga, Anurag Mehta, Avinash Rao
    Acta Cytologica.2022; 66(3): 187.     CrossRef
  • Predicting Factors for Pancreatic Malignancy with Computed Tomography and Endoscopic Ultrasonography in Chronic Pancreatitis
    Jian-Han Lai, Keng-Han Lee, Chen-Wang Chang, Ming-Jen Chen, Ching-Chung Lin
    Diagnostics.2022; 12(4): 1004.     CrossRef
  • Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study
    Wei Zhang, Ling Wang, Dan Li, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Qing Dong, Erkang Wang, Yuling Wang
    Analytical Methods.2022; 14(23): 2255.     CrossRef
  • Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment
    Wei Zhang, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Dingbin Liu, Yuling Wang
    Journal of Nanobiotechnology.2022;[Epub]     CrossRef
  • Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
    Maroun Bou Zerdan, Malek Shatila, Dhruv Sarwal, Youssef Bouferraa, Morgan Bou Zerdan, Sabine Allam, Merima Ramovic, Stephen Graziano
    Cancers.2022; 14(19): 4589.     CrossRef
  • Molecular Subtyping and Precision Medicine for Pancreatic Cancer
    Fieke Froeling, Raffaella Casolino, Antonio Pea, Andrew Biankin, David Chang
    Journal of Clinical Medicine.2021; 10(1): 149.     CrossRef
  • Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
    R. Casolino, C. Braconi, G. Malleo, S. Paiella, C. Bassi, M. Milella, S.B. Dreyer, F.E.M. Froeling, D.K. Chang, A.V. Biankin, T. Golan
    Annals of Oncology.2021; 32(2): 183.     CrossRef
  • Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Adenocarcinomas Revisited. A Detailed Cytological Analysis
    Mrinmay Kumar Mallik, Kusum Kapila, Asit Kumar Mohanty, Shafi Ahmed Inamdar, Ali AlAli, Abdullah Al Naseer
    Journal of Cytology.2021; 38(1): 31.     CrossRef
  • Diagnostic value of various liquid biopsy methods for pancreatic cancer
    Yuzhou Zhu, Hao Zhang, Nan Chen, Jianqi Hao, Hongyu Jin, Xuelei Ma
    Medicine.2020; 99(3): e18581.     CrossRef
  • Factors affecting cytological results of endoscopic ultrasound guided-fine needle aspiration during learning
    Jian-Han Lai, Hsiang-Hung Lin, Ching-Chung Lin
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Comparison between Conventional Smear and Liquid-Based Preparation in Endoscopic Ultrasonography-Fine Needle Aspiration Cytology of Pancreatic Lesions
    Soo Hee Ko, Jung-Soo Pyo, Byoung Kwan Son, Hyo Young Lee, Il Whan Oh, Kwang Hyun Chung
    Diagnostics.2020; 10(5): 293.     CrossRef
  • Evaluation of Pancreatic Lesions With Endoscopic Ultrasound and Fine Needle Aspiration
    Yan Luk, Wong Hoi She, Felix Che Lok Chow, Ka Wing Ma, Simon Hing Yin Tsang, Wing Chiu Dai, Tan To Cheung, Chung Mau Lo
    Surgical Innovation.2020; 27(5): 431.     CrossRef
  • The applicability of Papanicolaou Society of Cytopathology system on reporting endoscopic ultrasound‐guided fine needle aspiration cytology specimens of pancreatic lesions in situations with limited availability of ancillary tests. Experience at a single
    Mrinmay Kumar Mallik, Laila Rafiq Qadan, Abdullah Al Naseer, Ali AlAli, Taiba Al Ansari, Shafi Ahmed Inamdar Naquib, Dilip Kumar Das, Kusum Kapila
    Cytopathology.2020; 31(6): 564.     CrossRef
  • Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
    Marta Toledano-Fonseca, M. Teresa Cano, Elizabeth Inga, Rosa Rodríguez-Alonso, M. Auxiliadora Gómez-España, Silvia Guil-Luna, Rafael Mena-Osuna, Juan R. de la Haba-Rodríguez, Antonio Rodríguez-Ariza, Enrique Aranda
    Cancers.2020; 12(7): 1754.     CrossRef
  • Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology
    Raza S. Hoda, Elizabeth B. Finer, Ronald N. Arpin, Matthew Rosenbaum, Martha B. Pitman
    Journal of the American Society of Cytopathology.2019; 8(3): 120.     CrossRef
  • Endoscopic ultrasound guided fine‐needle aspiration vs core needle biopsy for solid pancreatic lesions: Comparison of diagnostic accuracy and procedural efficiency
    Aslam Syed, Olivia Babich, Bharat Rao, Shailendra Singh, Neil Carleton, Abhishek Gulati, Archana Kulkarni, Mrinal Garg, Katie Farah, Gursimran Kochhar, Suzanne Morrissey, Marcia Mitre, Abhijit Kulkarni, Manish Dhawan, Jan F. Silverman, Majed Pharaon, Shya
    Diagnostic Cytopathology.2019; 47(11): 1138.     CrossRef
  • Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
    Claudio Luchini, Nicola Veronese, Alessia Nottegar, Vera Cappelletti, Maria G. Daidone, Lee Smith, Christopher Parris, Lodewijk A. A. Brosens, Maria G. Caruso, Liang Cheng, Christopher L. Wolfgang, Laura D. Wood, Michele Milella, Roberto Salvia, Aldo Scar
    Cancers.2019; 11(8): 1152.     CrossRef
  • It is necessary to exam bottom and top slide smears of EUS-FNA for pancreatic cancer
    Jong-chan Lee, Haeryoung Kim, Hyoung Woo Kim, Jongchan Lee, Kyu-hyun Paik, Jingu Kang, Jin-Hyeok Hwang, Jaihwan Kim
    Hepatobiliary & Pancreatic Diseases International.2018; 17(6): 553.     CrossRef
  • Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancer
    Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park
    Gastrointestinal Endoscopy.2018; 88(6): 926.     CrossRef
  • Cytological characteristics of atypical cells in endoscopic ultrasound-guided fine-needle aspiration specimens obtained from the pancreas
    Shikine ESAKA, Yoko MATSUDA, Yuri HAMASHIMA, Masayuki IMAIZUMI, Hiroya KOJIMA, Yuri KISO, Hiroto SHIRAHATA, Mayumi KINOSHITA, Akemi SUZUKI, Tomio ARAI
    The Journal of the Japanese Society of Clinical Cytology.2018; 57(4): 199.     CrossRef
  • Performance measures for endoscopic retrograde cholangiopancreatography and endoscopic ultrasound: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
    Dirk Domagk, Kofi W Oppong, Lars Aabakken, Laszlo Czakó, Tibor Gyökeres, Gianpiero Manes, Peter Meier, Jan-Werner Poley, Thierry Ponchon, Andrea Tringali, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Cesare Hassan,
    United European Gastroenterology Journal.2018; 6(10): 1448.     CrossRef
  • Performance measures for ERCP and endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
    Dirk Domagk, Kofi W. Oppong, Lars Aabakken, Laszlo Czakó, Tibor Gyökeres, Gianpiero Manes, Peter Meier, Jan-Werner Poley, Thierry Ponchon, Andrea Tringali, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Cesare Hassan
    Endoscopy.2018; 50(11): 1116.     CrossRef
  • Imaging modalities for characterising focal pancreatic lesions
    Lawrence MJ Best, Vishal Rawji, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy
    Cochrane Database of Systematic Reviews.2017;[Epub]     CrossRef
  • Percutaneous ultrasound‐guided core needle biopsy of solid pancreatic masses: Results in 250 patients
    Guven Kahriman, Nevzat Ozcan, Serap Dogan, Soner Ozmen, Kemal Deniz
    Journal of Clinical Ultrasound.2016; 44(8): 470.     CrossRef
Transglutaminase 2 Expression and Its Prognostic Significance in Clear Cell Renal Cell Carcinoma
Min Jee Park, Hae Woon Baek, Ye-Young Rhee, Cheol Lee, Jeong Whan Park, Hwal Woong Kim, Kyung Chul Moon
J Pathol Transl Med. 2015;49(1):37-43.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.25
  • 9,100 View
  • 79 Download
  • 15 Web of Science
  • 17 Crossref
AbstractAbstract PDF
Background
A few recent studies have demonstrated a possible role of transglutaminase 2 (TG2) in tumorigenesis or progression of renal cell carcinoma (RCC). The aim of this study was to examine TG2 expression and its clinicopathologic significance in a large number of human clear cell RCCs (CCRCCs). Methods: We analyzed 638 CCRCC patients who underwent partial or radical nephrectomy between 1995 and 2005. The expression of TG2 was determined by immunohistochemistry and categorized into four groups, according to staining intensity: negative (0), mild (1+), moderate (2+), and strong (3+). Results: TG2 staining intensity was negative in 8.5% of CCRCC (n=54), 1+ in 32.6% (n=208), 2+ in 50.5% (n=322), and 3+ in 8.5% (n=54). Strong TG2 expression was correlated with high Fuhrman nuclear grade (p=.011), high T category (p=.049), metastasis (p=.043) and male sex (p<.001) but not with N category.The survival analysis showed a significant association between strong TG2 expression and worse overall and cancer-specific survival (p=.027 and p=.010, respectively). On multivariate analysis, strong TG2 expression was a marginally significant prognostic indicator for Fuhrman nuclear grade and TNM staging (p=.054). Conclusions: Our study is the first to demonstrate the clinicopathologic significance of TG2 expression in a large number of human CCRCC samples. Strong TG2 expression was associated with high nuclear grade and poor prognosis.

Citations

Citations to this article as recorded by  
  • Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma
    Ga-Ram Kim, Joon Hee Kang, Hyeon Joo Kim, Eunji Im, Jinsu Bae, Woo Sun Kwon, Sun Young Rha, Hyun Cheol Chung, Eun Yi Cho, Soo-Youl Kim, Yong-Chul Kim
    Bioorganic Chemistry.2024; 143: 107061.     CrossRef
  • Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target
    Patrizia Malkomes, Ilaria Lunger, Elsie Oppermann, Johannes Lorenz, Sara Fatima Faqar-Uz-Zaman, Jiaoyan Han, Sabrina Bothur, Paul Ziegler, Katrin Bankov, Peter Wild, Wolf Otto Bechstein, Michael A. Rieger
    Cancer Gene Therapy.2023; 30(10): 1346.     CrossRef
  • Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma
    Silvia Muccioli, Valentina Brillo, Tatiana Varanita, Federica Rossin, Elisabetta Zaltron, Angelo Velle, Giorgia Alessio, Beatrice Angi, Filippo Severin, Anna Tosi, Manuela D’Eletto, Luca Occhigrossi, Laura Falasca, Vanessa Checchetto, Roberto Ciaccio, Ame
    Cell Death & Disease.2023;[Epub]     CrossRef
  • The role of transglutaminase 2 in regulation of the balance between autophagy and apoptosis in tumor cells
    Yu. A. Gnennaya, O.  M. Semenov, N. A. Barlev
    Advances in Molecular Oncology.2023; 10(4): 31.     CrossRef
  • Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates
    Sandra Hauser, Paul Sommerfeld, Johanna Wodtke, Christoph Hauser, Paul Schlitterlau, Jens Pietzsch, Reik Löser, Markus Pietsch, Robert Wodtke
    International Journal of Molecular Sciences.2022; 23(9): 4475.     CrossRef
  • The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment
    Robert Tempest, Sonia Guarnerio, Rawan Maani, Jamie Cooper, Nicholas Peake
    Cancers.2021; 13(11): 2788.     CrossRef
  • A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
    Soo-Youl Kim, Jeffrey W. Keillor
    International Journal of Molecular Sciences.2020; 21(7): 2493.     CrossRef
  • Evaluation of nuclear NF-κB, transglutaminase2, and ERCC1 as predictors of platinum resistance in testicular tumors
    Alan A. Azambuja, Paula Engroff, Bruna T. Silva, Roberta C. S. Zorzetti, Fernanda B. Morrone
    International braz j urol.2020; 46(3): 353.     CrossRef
  • Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma
    Seon-Hyeong Lee, Joon Hee Kang, Ji Sun Ha, Jae-Seon Lee, Su-Jin Oh, Hyun-Jung Choi, Jaewhan Song, Soo-Youl Kim
    International Journal of Molecular Sciences.2020; 21(14): 5042.     CrossRef
  • Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression
    Burge Ulukan, Ajna Bihorac, Tarik Sipahioglu, Robert Kiraly, Laszlo Fesus, Dilek Telci
    ACS Omega.2020; 5(43): 28273.     CrossRef
  • Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma
    Ayca Ece Nezir, Burge Ulukan, Dilek Telci
    Medical Sciences.2019; 7(2): 24.     CrossRef
  • Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target
    Richard L. Eckert
    Molecular Carcinogenesis.2019; 58(6): 837.     CrossRef
  • Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus
    Nayeon Kim, Joon Hee Kang, Won-Kyu Lee, Seul-Gi Kim, Jae-Seon Lee, Seon-Hyeong Lee, Jong Bae Park, Kyung-Hee Kim, Young-Dae Gong, Kwang Yeon Hwang, Soo-Youl Kim
    Amino Acids.2018; 50(11): 1583.     CrossRef
  • Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition
    Seon-Hyeong Lee, Won-Kyu Lee, Nayeon Kim, Joon Hee Kang, Kyung-Hee Kim, Seul-Gi Kim, Jae-Seon Lee, Soohyun Lee, Jongkook Lee, Jungnam Joo, Woo Sun Kwon, Sun Young Rha, Soo-Youl Kim
    Cancers.2018; 10(11): 455.     CrossRef
  • Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma
    Yesim Bagatur, Ayca Zeynep Ilter Akulke, Ajna Bihorac, Merve Erdem, Dilek Telci
    Cell Adhesion & Migration.2017; : 1.     CrossRef
  • Characterization of clear cell renal cell carcinoma by gene expression profiling
    Bryan J. Thibodeau, Matthew Fulton, Laura E. Fortier, Timothy J. Geddes, Barbara L. Pruetz, Samreen Ahmed, Amy Banes-Berceli, Ping L. Zhang, George D. Wilson, Jason Hafron
    Urologic Oncology: Seminars and Original Investigations.2016; 34(4): 168.e1.     CrossRef
  • Prognostic role of tissue transglutaminase 2 in colon carcinoma
    María Jesús Fernández-Aceñero, Sofía Torres, Irene Garcia-Palmero, Cristina Díaz del Arco, J. Ignacio Casal
    Virchows Archiv.2016; 469(6): 611.     CrossRef
Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status
Jung Ho Kim, Jeong Mo Bae, Kyung-Ju Kim, Ye-Young Rhee, Younghoon Kim, Nam-Yun Cho, Hye Seung Lee, Mee Soo Chang, Gyeong Hoon Kang
Korean J Pathol. 2014;48(4):276-282.   Published online August 26, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.4.276
  • 10,829 View
  • 61 Download
  • 15 Crossref
AbstractAbstract PDF
Background

Recent studies have revealed that a small subset of Lynch syndrome-associated colorectal carcinomas (CRCs) is caused by a germline EPCAM deletion-induced MSH2 epimutation. Based on the finding of this genetic alteration, we investigated the implications of EPCAM expression changes in microsatellite instability-high (MSI-H) CRCs.

Methods

Expression of EPCAM and DNA mismatch repair proteins was assessed by immunohistochemistry in 168 MSI-H CRCs. Using DNA samples of these tumors, MLH1 promoter methylation status was also determined by methylation-specific real-time polymerase chain reaction method (MethyLight).

Results

Among 168 MSI-H CRCs, complete loss (CL) and focal loss (FL) of EPCAM expression was observed in two (1.2%) and 22 (13.1%) cases, respectively. Both of the EPCAM-CL cases were found in MSH2-negative tumors without MLH1 promoter methylation. However, only nine of the 22 EPCAM-FL tumors had MSH2 deficiency. Of the 22 EPCAM-FL tumors, 13 showed MLH1 loss, and among them, nine cases were determined to have MLH1 methylation. EPCAM-FL was significantly associated with advanced stage (p=.043), distant metastasis (p=.003), poor differentiation (p=.001), and signet ring cell component (p=.004).

Conclusions

Loss of EPCAM expression is differentially associated with clinicopathological and molecular features, depending on the completeness of the loss, in MSI-H CRCs.

Citations

Citations to this article as recorded by  
  • Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs
    Xingyu Jiang, Sumeng Wang, Qi Liang, Yiqian Liu, Lingxiang Liu
    Medical Oncology.2023;[Epub]     CrossRef
  • Outcomes of Definitive Treatment of Signet Ring Cell Carcinoma of the Rectum: Is Minimal Invasive Surgery Detrimental in Signet Ring Rectal Cancers?
    S. Raghavan, Deepak Kumar Singh, J. Rohila, A. DeSouza, R. Engineer, A. Ramaswamy, V. Ostwal, A. Saklani
    Indian Journal of Surgical Oncology.2020; 11(4): 597.     CrossRef
  • Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients
    Ippokratis Messaritakis, Maria Sfakianaki, Konstantinos Vogiatzoglou, Asimina Koulouridi, Chara Koutoulaki, Dimitrios Mavroudis, Maria Tzardi, Nikolaos Gouvas, John Tsiaoussis, John Souglakos
    Journal of Personalized Medicine.2020; 10(4): 235.     CrossRef
  • Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis
    Susu Han, Shaoqi Zong, Qi Shi, Hongjia Li, Shanshan Liu, Wei Yang, Wen Li, Fenggang Hou
    EBioMedicine.2017; 20: 61.     CrossRef
  • Prognostic factors in sporadic colon cancer with high-level microsatellite instability
    Bo Young Oh, Jung Wook Huh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
    Surgery.2016; 159(5): 1372.     CrossRef
  • Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status
    Ghilsuk Yoon, Hwayoung Lee, Jae-Hoon Kim, Keun Hur, An Na Seo
    Tumor Biology.2016; 37(8): 10209.     CrossRef
  • Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis
    Raj Thani Somasundaram, Jatinder Kaur, Iona Leong, Christina MacMillan, Ian J. Witterick, Paul G. Walfish, Ranju Ralhan
    BMC Cancer.2016;[Epub]     CrossRef
  • BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis
    Soo Kyung Nam, Sumi Yun, Jiwon Koh, Yoonjin Kwak, An Na Seo, Kyoung Un Park, Duck-Woo Kim, Sung-Bum Kang, Woo Ho Kim, Hye Seung Lee, Wayne A Phillips
    PLOS ONE.2016; 11(3): e0151865.     CrossRef
  • Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells
    Bo Young Oh, So-Young Kim, Yeo Song Lee, Hye Kyung Hong, Tae Won Kim, Seok Hyung Kim, Woo Yong Lee, Yong Beom Cho
    Oncotarget.2016; 7(35): 57066.     CrossRef
  • Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
    Jung Ho Kim, Jeong Mo Bae, Young Seok Song, Nam-Yun Cho, Hye Seung Lee, Gyeong Hoon Kang
    Oncotarget.2016; 7(12): 13372.     CrossRef
  • Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
    Jung Ho Kim, Jeong Mo Bae, Hyeon Jeong Oh, Hye Seung Lee, Gyeong Hoon Kang
    Journal of Pathology and Translational Medicine.2015; 49(2): 118.     CrossRef
  • HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value
    An Na Seo, Yoonjin Kwak, Woo Ho Kim, Duck-Woo Kim, Sung-Bum Kang, Gheeyoung Choe, Hye Seung Lee
    Virchows Archiv.2015; 466(6): 645.     CrossRef
  • Clinical and prognostic value of MET gene copy number gain and chromosome 7 polysomy in primary colorectal cancer patients
    An Na Seo, Kyoung Un Park, Gheeyoung Choe, Woo Ho Kim, Duck-Woo Kim, Sung-Bum Kang, Hye Seung Lee
    Tumor Biology.2015; 36(12): 9813.     CrossRef
  • c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer
    Kyu Sang Lee, Yoonjin Kwak, Kyung Han Nam, Duck-Woo Kim, Sung-Bum Kang, Gheeyoung Choe, Woo Ho Kim, Hye Seung Lee, Andreas Krieg
    PLOS ONE.2015; 10(10): e0139727.     CrossRef
  • Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
    Gunjan Srivastava, Jasmeet Assi, Lawrence Kashat, Ajay Matta, Martin Chang, Paul G Walfish, Ranju Ralhan
    BMC Cancer.2014;[Epub]     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP